Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Prime Medicine is a biotechnology company specializing in developing precise, one-time gene editing therapies using its proprietary Prime Editing technology. Focused on genetic diseases like chronic granulomatous disease and Wilson’s disease, it aims to correct mutations across various tissues and cell types. The company leverages innovative delivery platforms and strategic partnerships to create durable, potentially curative treatments with broad therapeutic applications.
This description was generated via AI from an annual report. Updated about 1 year ago.